Home › Markets › Industrials › BIOX

Bioceres Crop Solutions Corp. (BIOX)

BIOX trades on Nasdaq in Industrials, Agricultural Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.3250
-1.81% on the day
Market cap
$20.7M
Nano cap
Revenue · 2025
$335.1M
No prior year to compare
Net income · 2025
-$55.4M
-16.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-06-30, https://www.sec.gov/Archives/edgar/data/1769484/000110465925108999/0001104659-25-108999-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-06-30.

Profile

FieldValue
TickerBIOX on Nasdaq
SectorIndustrials
IndustryAgricultural Chemicals
CountryArgentina
IPO yearNot reported by the screener
SEC CIK0001769484
SEC industry codeAgricultural Chemicals
Incorporated inE9

Financials · 2025

LineValue
Revenue$335.1M
Net income-$55.4M
Operating incomeNot in SEC XBRL data
Net margin-16.5%
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
CashNot in SEC XBRL data
Total assetsNot in SEC XBRL data
P/E (computed)Net income was not positive
P/S (computed)0.1×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32025-01-22
Latest annual report20-F2025-11-10
Latest quarterly / interim
FORM 6-K
6-K2026-09-21

Source: SEC EDGAR submissions feed, 279 recent filings. All filings on EDGAR.

Peers in Agricultural Chemicals

TickerCompanyPriceDayMarket cap
AVDAmerican Vanguard Corporation Common Stock ($0.10 Par Value)$1.33-5.67%$39.2M
FRTTFort Technology Inc. Common Shares$0.6960-7.08%$10.5M
EVGNEvogene Ltd$0.3902+0.96%$6.2M
CBUSCibus Inc.$1.41-4.73%$107.8M
SNESSenesTech Inc.$0.6293-2.87%$3.4M
NXTSNexentis Technologies Inc.$0.7038-6.88%$1.0M
UANCVR Partners LP Common Units representing Limited Partner Interests$126.21+0.57%$1.3B
SMGScotts Miracle-Gro Company (The)$50.10+0.32%$2.9B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier